It is said that with age comes “wisdom”; however, I often think that “exhaustion” might serve as a reasonable substitute. As we deal with life’s stresses, and new hairs sprout of snowy white hues, it is hard not to think of our younger days of freedom and vitality.
If I could anthropomorphize a cell, I would think that this is precisely how a cancer-fighting T-cell feels.
T-cells, as you may know, are the champions of our adaptive immune system. Each T-cell will recognize a specific foreign invader (e.g. cancer) and when it meets that invader, it will proliferate to create an army against it. Some invaders are easy to kill, but if T-cells are fighting a particularly difficult tumor they sometimes get, well … worn out.
For this reason, a Japanese research team sought to create a special type of cell transfer immunotherapy that involves rejuvenating a patient’s cancer specific T-cells to their former glory. In their recent study published in Cell Stem Cell, Vizcardo et al. show that they can take melanoma-specific T-cells, dedifferentiate them into induced pluripotent stem cells, and redifferentiate them into functional T-cells that are specific for the same tumor. While this dedifferentiation-redifferentiation strategy may seem rather cyclical and pointless, the idea is that the recreated T-cells are more youthful and stem cell-like in nature, with a restored ability to proliferate and fight the tumor long term.
This study is impressive because the creation of mature T-cells from less differentiated precursors is a very complex and elegant process, which the authors seem to have been able to replicate (to a certain extent). One can imagine that an advantage of using cancer-specific T cells over chemotherapies and radiation therapies is that the damage will be more specific to the tumor with fewer systemic side effects.
Although the authors have yet to rigorously test the endurance of their recreated T-cells for fighting cancer, and induced pluripotent stem cell technology is not yet clinically translatable (although this challenge may soon be overcome and indeed research released earlier this week suggests iPS cells are safer than previously thought), the concept of taking out our weary, old cells and giving them a regenerative boost is rather compelling.
It’s not quite your typical day at the spa but may nevertheless prove interesting to follow over the next decade.
Latest posts by Holly Wobma (see all)
- Oldies but still goodies: how we continue to transform the field of haematopoietic stem cells - April 9, 2013
- Gaining ground on losing pounds: How a little more fat might help combat the obesity crisis - February 5, 2013
- Rejuvenation therapy for our aging T-cells (and what it may mean to cancer treatment) - January 10, 2013